Haywood's new report on RBM with comments and valuation updates given the Roche deal. <a href="http://www.haywood.com/pdffiles/RBMJun272008.pdf" target="_blank">http://www.haywood.com/pdffiles/RBMJun272008.pdf</a> Note new price target is $1.60 up $0.5 <!--Beg_Sig-->